Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rivera

Showing results (661-670 of 680) with videos related to

Pageof 68
Sort By:
Blood Cancer Journal|August 11, 2023
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive eventsMaymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, et al.
Nature Microbiology|April 17, 2019
Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA virusesDaisuke Yamane, Hui Feng, Efraín E Rivera-Serrano, et al.
Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.
Cell Reports. Medicine|February 26, 2026
Delayed viral rebound post-ART interruption in infant macaques given SIV-specific neutralizing antibodiesJenna S Powers, Katherine M Bricker-Holt, Brianna Williams, et al.
Transplantation Direct|July 26, 2023
Portopulmonary Hypertension: An Updated ReviewErick A Jasso-Baltazar, Gonzalo A Peña-Arellano, Jonathan Aguirre-Valadez, et al.
Blood|October 6, 2016
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomibShaji K Kumar, Betsy R LaPlant, Craig B Reeder, et al.
Open Forum Infectious Diseases|August 31, 2022
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019Jin Yong Kim, Oana Săndulescu, Liliana-Lucia Preotescu, et al.
Leukemia & Lymphoma|March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.
Plos Biology|June 15, 2021
Promoting inclusive metrics of success and impact to dismantle a discriminatory reward system in scienceSarah W Davies, Hollie M Putnam, Tracy Ainsworth, et al.
Urolithiasis|December 12, 2022
Heterogeneity in stone culture protocols and endourologist practice patterns: a multi-institutional surveyDavid T Tzou, Karen L Stern, Brian D Duty, et al.
Pageof 68

Showing results (661-670 of 680) with videos related to

Sort By:
Pageof 68
Blood Cancer Journal|August 11, 2023
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive eventsMaymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, et al.
Nature Microbiology|April 17, 2019
Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA virusesDaisuke Yamane, Hui Feng, Efraín E Rivera-Serrano, et al.
Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.
Cell Reports. Medicine|February 26, 2026
Delayed viral rebound post-ART interruption in infant macaques given SIV-specific neutralizing antibodiesJenna S Powers, Katherine M Bricker-Holt, Brianna Williams, et al.
Transplantation Direct|July 26, 2023
Portopulmonary Hypertension: An Updated ReviewErick A Jasso-Baltazar, Gonzalo A Peña-Arellano, Jonathan Aguirre-Valadez, et al.
Blood|October 6, 2016
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomibShaji K Kumar, Betsy R LaPlant, Craig B Reeder, et al.
Open Forum Infectious Diseases|August 31, 2022
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019Jin Yong Kim, Oana Săndulescu, Liliana-Lucia Preotescu, et al.
Leukemia & Lymphoma|March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.
Plos Biology|June 15, 2021
Promoting inclusive metrics of success and impact to dismantle a discriminatory reward system in scienceSarah W Davies, Hollie M Putnam, Tracy Ainsworth, et al.
Urolithiasis|December 12, 2022
Heterogeneity in stone culture protocols and endourologist practice patterns: a multi-institutional surveyDavid T Tzou, Karen L Stern, Brian D Duty, et al.
Pageof 68